Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3Breast 3Thoracic 2Gastrointestinal 2Other neoplasm 1Gynecologic 1Genitourinary 1

Conditions

Breast Neoplasms 3Pain, Postoperative 1

Interventions

Cyclophosphamide 423Trastuzumab 414Paclitaxel 375Docetaxel 314Capecitabine 266Letrozole 262Carboplatin 257Doxorubicin 213Tamoxifen 184Fulvestrant 176Epirubicin 176Radiotherapy 171Anastrozole 164pembrolizumab 152pertuzumab 147Surveys and Questionnaires 146Exercise 142exemestane 128Vinorelbine 127palbociclib 124Bevacizumab 123Magnetic Resonance Spectroscopy 120Blood Specimen Collection 120Drug Therapy 106Albumin-Bound Paclitaxel 105Gemcitabine 99130-nm albumin-bound paclitaxel 98pyrotinib 92eribulin 90Biopsy 88

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Epinephrine × Breast × Clear all
NCT04603911 2025-01-10

RCT Comparing ESPB Solutions in Breast Surgery

Tufts Medical Center

Phase 2 Completed
75 enrolled
Breast

Breast Neoplasms

NCT02659501 2021-01-12

Liposomal Bupivacaine in Implant Based Breast Reconstruction

Loma Linda University

Phase NA Terminated
24 enrolled 10 charts
Breast

Breast Neoplasms, Pain, Postoperative

NCT02525718 2019-08-14

Selective Intraoperative Administration of Local Anesthesia in Breast Reconstruction

Northwestern University

Phase 2 Completed
47 enrolled 7 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡